Safety, Tolerability and Preliminary Efficacy of JK1201I in Patients With SCLC
Clinical trial NCT05158491 · UNKNOWN
Trial details
- NCT number
- NCT05158491
- Sponsor
- JenKem Technology Co., Ltd.
- Status
- UNKNOWN
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-11-11
- Primary completion
- 2022-12-31
- Enrollment
- 63
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.